RayzeBio (RYZB) 30-day option implied volatility near upper end of range
Tweet
Share
E-mailGet Alerts RYZB Hot Sheet
Join SI Premium – FREE
RayzeBio (NASDAQ: RYZB) 30-day option implied volatility is at 91; compared to its 52-week range of 20 to 94 into Bristol Myers (BMY) to acquire RayzeBio for $62.50 per share in cash.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron Technology (MU) call put ratio 1.3 calls to 1 put into quarter results
- Western Digital (WDC) call put ratio 1 call to 1.2 puts into Micron (MU) quarter results
- Sandisk (SNDK) call put ratio 1 call to 1.1 puts into Micron (MU) quarter results
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, Definitive Agreement, bmySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
